The recombinant Lonomia obliqua Stuart-factor activator (rLosac) is a recombinant hemolin which belongs to the immunoglobulin superfamily of cell adhesion molecules. It is capable of inducing pro-survival activity in serum-deprived human umbilical vein endothelial cells (HUVECs) and fibroblasts by increasing mitochondrial metabolism. We hypothesize that it could promote neuronal survival by acting on neuroenergetics. Our study reveals that treatment of primary mouse cortical neurons cultured in neurobasal medium lacking B27 supplement with rLosac led to an enhancement of cell viability in a time-and concentration-dependent manner. In parallel, preserved or enhanced phosphorylation of Akt, p44, and p42 MAPK, as well as mTOR was observed following treatment with rLosac. During deprivation, as assessed by western blot and qRT-PCR, protein and mRNA expression of MCT2 (the predominant neuronal monocarboxylate transporter allowing lactate use as an alternative energy substrate) decreased
significantly in B27 supplement-deprived cortical neurons and was hardly detected after 24 h of deprivation. Interestingly, rLosac maintained MCT2 protein expression after 24 h of deprivation including at the cell surface without preventing mRNA loss. MCT2 knockdown reduced rLosac-enhanced cell viability, confirming its involvement in rLosac effect. Enhanced uptake of lactate was detected following rLosac treatment and might contribute to rLosac-enhanced viability during deprivation. In the presence of both lactate and rLosac, cell viability was higher than in the presence of lactate alone. Our observations suggest that rLosac promotes cell viability in stressed (B27 supplement-deprived) neurons by facilitating the use of lactate as energy substrate via the preservation of MCT2 protein expression. Keywords: energy, hemolin, lactate, MCT2, neuroprotection, rLosac. J. Neurochem. (2019) 148, 80--96. rLosac is the recombinant form of a 45 KDa protein from the bristle of Lonomia obliqua caterpillar. It belongs to the immunoglobulin superfamily of cell adhesion molecules (CAM) sharing different degrees of similarity with neural CAMs involved in the development of the nervous system and critical for neurite outgrowth: hemolin from other lepidopters (47-76%), neuroglian from D. melanogaster (34%), and L1-NCAM (L1 family neural cell adhesion molecules) from humans (26%) (Alvarez-Flores et al. 2011) . rLosac is capable of inducing proliferation and reducing apoptosis in serumdeprived HUVECs (Alvarez-Flores et al. 2006) . In fibroblasts, it was suggested that rLosac's cytoprotective activity under stress conditions such as serum deprivation is related to a reduction in oxidative stress, preventing damage and loss of mitochondrial function as well as reducing caspase 3 activity and therefore apoptosis (Alvarez-Flores et al. 2011; Bosch et al. 2016) . Similar observations were made in serumdeprived endothelial cells (HUVECs), in which rLosac promotes cell viability through the activation of survival pathways [e.g. ERK1/2 MAPK] in the first hours following exposure to rLosac (M.P. Alvarez-Flores' unpublished data).
Monocarboxylate transporters form a small group of proteins playing an important role in allowing energy substrates such as lactate, pyruvate, and ketone bodies to cross the plasma membrane (Pierre and Pellerin 2005) . The isoforms MCT1, MCT2, and MCT4 have been shown to be expressed by specific cell types in the rodent brain (Pierre and Pellerin 2005) . MCT2 is predominantly expressed by neurons, and is the major MCT isoform responsible for the uptake of lactate and its subsequent use as an additional energy substrate by this cell type (Pierre et al. 2000 (Pierre et al. , 2002 . The prominent postsynaptic localization of MCT2 suggested a link between synaptic transmission and neuronal energy supply via this transporter (Pierre and Pellerin 2005; Pierre et al. 2009) . Besides being present in the plasma membrane (Pierre and Pellerin 2005) , MCT2 has been reported to be located in the mitochondrial membrane where it could contribute to sustain oxidative phosphorylation (Benton et al. 2004) . Several studies suggested that nutritional modifications may regulate MCT expression in the central nervous system (Pierre and Pellerin 2005) . In parallel, reductions in MCT expression have been associated with pathologies such as neurodegenerative diseases, cognitive impairments, and metabolic disorders (Perez-Escuredo et al. 2016) . Interestingly, over-expression of MCT2 has been shown to offer neuroprotection against excitotoxic stress (Bliss et al. 2004) .
Under starvation or stress conditions, cells respond by limiting energy consumption to survive, activating mechanism of translational control to down-regulate protein production (Ma and Blenis 2009) . In neurons, B27 supplement deprivation significantly reduced phosphorylation of phosphoinositide 3 kinase (PI3K)/Akt/mTOR and ERK1/2 (p42/p44) MAP kinase signaling pathways in cortical and hippocampal neurons (Young et al. 2009; Park et al. 2014) . The activation of those pathways promotes neuronal survival, modulating signaling for neuronal cell proliferation, migration, and plasticity (Morrison et al. 2002) . Interestingly, the PI3K/Akt/mTOR and ERK1/2 (p42/p44) MAPK pathways have been shown to be involved in the translational regulation of MCT2 expression, which is modulated by several factors associated with neuronal survival such as insulin, insulin-related peptide insulin-like growth factor-1 (IGF-1) and brain-derived neurotrophic factor (BDNF) (Chenal et al. 2008; Robinet and Pellerin 2010) .
In that context, we hypothesized that rLosac, a cytoprotective molecule, may also promote neuroprotection by regulating MCT2 expression in neurons. To investigate this hypothesis, B27 supplement-deprived cortical neurons were treated with rLosac to examine its effect on cell viability, on changes in cell survival signaling pathways as well as on MCT2 expression and lactate uptake. Results obtained extend previous observations to brain cells, by showing that rLosac provide neuroprotection to stressed neurons. In addition, they also reveal that such an effect is obtained through regulation of MCT2 protein expression, thus facilitating the use of lactate as an energy substrate by these cells. These data highlight the importance of lactate and MCT2 for survival of cortical neurons under stress conditions.
Materials and methods

Chemicals and reagents
The recombinant protein Losac (rLosac) was produced as described previously (Alvarez-Flores et al. 2011) . Briefly, competent E.Coli BL21 (DE3) strain was transformed with the pAE-Losac plasmid which encodes a 48.6 kDa Losac protein fused to a minimal Nterminal His6-tag. The recombinant protein was recovered in inclusion bodies after cell lysis with urea and subjected to refolding and purification. Thiazolyl blue tetrazolium bromide (MTT reagent, Cat# 2128) came from Sigma-Aldrich (St. Louis, Missouri, USA). Sodium dodecyl sulfate (Cat# 161-0418) came from Bio-Rad (Hercules, CA, USA). Lipofectamine 3000 Reagent (Lipo 3000, Cat# L3000-008) was purchased from Invitrogen (Carlsbad, CA, USA). Neurobasal Medium minus phenol red (Cat# 12348), B27 supplement 50X (Cat# 17504-001), penicillin-streptomycin (Cat# 15140), Opti-MEM (Cat# 31985-062), and GlutaMax (Cat# 350505) were purchased from Gibco (Carlsbad, CA, USA). RNeasy Mini Kit (Cat# 74106), a non-silencing siRNA scrambled (Cat# 1027281, AllStars Neg. control siRNA with no homology to any known mammalian gene), and a validated MCT2-targeted siRNA (siMCT2, target sequence TAGGATTAATAGCCAACACTA) (Maekawa et al. 2008 (Maekawa et al. , 2009 were purchased from Qiagen (Hombrechtikon, Switzerland). RT High-Capacity RNA-to-cDNA Kit (Cat# 4368814) and Power SYBR Green PCR Master Mix (Cat# 4367559) were obtained from Applied Biosystems (Rotkreuz, Switzerland). All other chemicals used were of the highest purity available on the market.
Plasmid cloning
The MCT2 transcript (Slc16a7) was cloned from a 2-month-old mouse hippocampus (C57BL/6J) and during this step the AttB1 and AttB2 recombinant sequences were added (For:ggggacaagtttgtacaaaaaagcaggcttcATGCCATCAGAGCCTTCCGCG, Rev:ggggaccactttgtacaagaaagctgggttAATATTACTCTCTTTGTCCCT; upper cases and lower cases, respectively, correspond to the MCT2 sequence and AttB). The AttB-flanked PCR product was inserted in a pDONR TM 221 Vector (Cat#12536017, Thermo Fisher Scientific) using BP clonase following the manufacturer's protocol (Cat#11789-020, Invitrogen). The MCT2 sequence was then transferred into the destination plasmid pcDNA-GFPCter using LR clonase (Cat#11791020, Thermo Fisher Scientific). The empty mCherry plasmid corresponds to a pcDNA-mCherry (Gateway system, ThermoFischer Scientific).
Primary cultures of mouse cortical neurons preparation and treatments
The experimental procedures were approved by the Service de la Consommation et des Affaires V et erinaires du Canton de Vaud, under the animal authorization VD1251.4. All efforts were made to minimize the number of animals used. This study was not preregistered. Primary cultures of mouse cortical neurones were prepared from OF1 mice (research resource identifier (RRID): IMSR_CRL:612), Charles River, Lyon, France) at embryonic day 18 as described previously (Debernardi et al. 2003) . No sample size calculation was performed to predetermine the sample size. OF1 mice were individually housed in a temperature-controlled environment (12 h light/12 h dark cycle, 25°C) with ad libitum access to food and water. Pregnant female were killed by rapid cervical dislocation, the pups immediately removed and killed by decapitation. After brain dissection, cortices were isolated and mechanically dissociated in Hank's balanced salt solution (HBSS) (composition in mM: 5.3 KCl, 0.44 KH 2 PO 4 , 145 NaCl, 0.34 NaHPO4, 5.6 Dglucose, 0.03 phenol red, 10 Hepes-Na, 1.3 CaCl 2 -2H 2 O, 0.5 MgCl 2 -6H 2 O, 0.4 MgSO 4 -7H 2 O, pH 7.2) containing penicillin streptomycin. Cells were plated on 15 mg/ml poly-ornithine-coated 96-well and 6-well plates at a density of 5x10 4 (for cell viability studies) and 4 9 10 5 cells/well (for the other assays), respectively, and maintained in neurobasal medium containing B27-supplement, GlutaMax, and penicillin-streptomycin [referred to as neurobasal complete medium (NBC)], at 37°C and 5% CO 2 (Brewer et al., 1993) . For plasmid transfections, neurons were plated in 24-well plates at a density of 2 x10
5
. After 5 DIV, neurons were transfected with both GFP-MCT2 and mCherry-containing plasmids (1500 ng per plasmid) using Lipofectamine 3000 reagent (Thermo Fisher, L3000015) in 250 lL medium. After 5 h, 800 lL of NBC without antibiotics was added to each well. All other experiments were carried out at 7 DIV. For deprivation conditions, primary neurons were cultured in neurobasal medium without B27 supplement (hereafter called nutrient deprivation or Ctrl) in the presence or absence of rLosac at the concentrations and times indicated in the figures. For western blotting, cortical neurons were submitted to B27 supplement deprivation during 4 h for evaluating phosphorylation of cell signaling proteins (Akt, ERK, mTOR) before treatment with 20 nM rLosac.
Cell viability assays
Cortical neurons were cultured in deprivation conditions and the presence or absence of different concentrations of rLosac for different times. Morphological changes were analyzed by phasecontrast microscopy. Lactate dehydrogenase (LDH) release was quantified in 50 lL supernatants using the Cytotox 96 NonRadioactive Cytotoxicity assay (Cat# G1780, Promega, Madison, WI, USA) following the manufacturer's instructions assay. Values were expressed as percentage of maximum LDH release (set at 100%) obtained through total lysis of some cultured cells. In monolayers, cell viability was assessed with the MTT colorimetric assay (Mosmann 1983 ) by incubating cells during 3 h at 37°C with 100 lL of 0.5 mg/mL MTT reagent in phosphate-buffered saline. MTT reagent was removed and formazan crystals were solubilized in 100 lL of dimethylsulfoxide during 5 min. The absorbance was read at 540 nm using the Synergy Mx microplate reader (BioTek Instruments, Switzerland) . The percentage of cell viability was determined from the absorbance at 540 nm of the experimental group (sample or deprived controls, Ctrl) divided by the absorbance of untreated neurons cultured in NBC 9 100%".
Quantitative Real-Time RT-PCR analysis Gene expression measurements were performed in B27-deprived neurons treated with 20 nM rLosac for various periods of time. Culture medium was removed and total RNA was isolated using RNeasy Mini Kit following the manufacture's instruction. For cDNA synthesis, 200 ng of total RNA were converted to cDNA in a volume of 50 lL using the RT High-Capacity RNA-to-cDNA Kit. One microliter of cDNA samples and 0.3 lM of each primer were mixed with Power SYBR Green PCR Master Mix in a total reaction volume of 10 lL, in triplicate, for real time PCR analysis using the StepOnePlus (Applied Biosystems) for relative quantitation. Relative quantitation of gene expression was based on the comparative CT method using the 2 ÀDDCT method.
Western blotting
Cortical neurons were sonicated and homogenized in radioImmunoprecipitation assay lysis buffer (Cat# 20-188, Millipore, Billerica, USA) supplemented with 1% sodium dodecyl sulfate, 5 mM EDTA and a cocktail of proteinase inhibitors (Cat# 04-693-116-001, Roche, Basel, Switzerland). Protein quantification was performed with the Pierce bicinchoninic acid Protein Assay kit (Cat# 23227 Thermo Fisher Scientific, Pierce, Lausanne, Switzerland) and approximately 15 lg of total cell lysate was separated with 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis, transferred to nitrocellulose membranes and incubated for 1 h with blocking solution: 5% non-fat milk prepared in TBS-T (10 mM Tris-HCl, pH 7.5, 150 mM NaCl; containing 0.1% Tween-20). Primary rabbit monoclonal antibodies (Cell Signaling, Berverly, MA, USA) against b-tubulin (9F3) (Cat# 2128, RRID: AB_823664), total mTor (Cat# 2972, RRID: AB_330978) and phospho-mTor (Ser2448) (Cat# 2971, RRID: AB_330970), Akt (Cat# 4691, RRID: AB_915783) and phospho-Akt (Ser473) (Cat# 9271, RRID: AB_330970), p44/p42 MAPK (Cat# 9102, RRID: AB_330744) and phospho-p44/p42 MAPK (Thr202/Tyr204) (Cat# 9101, RRID: AB_331646) were diluted 1:1000 in blocking solution and incubated overnight at 4°C with blocked membranes. We also used a primary polyclonal rabbit anti-MCT2 antibody, a homemade antibody previously characterized (Pierre et al. 2000) . The specific band for each protein was detected using the secondary antibody donkey anti-rabbit-HRP linked (Cat# NA9340, RRID: AB_772191, GE Healthcare, Glattbrugg, Switzerland) diluted 1 : 10 000 in TBS-T and incubated for 1 h at 25°C prior to detection with western blotting detection kits (Cat# K-12045-D50, Advansta, CA, USA) and revealed with the ChemiDoc XRS System (Bio-Rad, Cressier, Switzerland). Densitometry analysis was performed using the ImageLab 3.0 software (Bio-Rad).
Lactate uptake
The procedure was as described previously (Marcillac et al. 2011) . Neurons (4x10 5 cells in poly-ornithine-pre-coated 35 mm dishes)
were treated with 20 nM Losac for 24 h under B27-deprivation conditions. Then, neurons were washed twice in Krebs ringer phosphate hepes buffer (20 mM Hepes, pH 7.3, containing 136 mM NaCl, 1 mM CaCl 2 , 4.7 mM KCl, 1.25 mM MgSO4.7H 2 O, 5 mM NaH 2 PO 4 .H 2 O) and incubated for 30 seconds at 37°C and 5% CO 2 in 1 mL Krebs ringer phosphate hepes buffer containing 0.5 lCi/ml L-[ 14 C] lactic acid (sodium salt) (#ARC-0479, American Radiolabeled Chemicals, St Louis, MO, USA). The reaction was stopped by washing cells two times with ice-cold phosphate-buffered saline. Then, cells were lysed with 1 mL 0.1 N NaOH and 0.1% Triton X-100. The lysate was collected into scintillation vials for quantification of 14 C-lactate radioactivity by liquid scintillation counting using a Tri-Carb 2300TR Liquid Scintillation Analyzer (PerkinElmer). Counts were normalized for protein content using the Pierce bicinchoninic acid Protein Assay kit.
Transfection and siRNA knockdown For the suppression of endogenous MCT2 expression (MCT2 silencing), Lipofectamine 3000 was used according to the manufacturer's instruction (Thermo Fisher, Cat# L3000015). Transfection mixtures were prepared in a final volume of 750 lL/well of neurobasal medium without antibiotics containing 250 lL Opti-MEM, 300 nM scrambled or siRNA MCT2 and 7.5 lL Lipofectamine 3000. Cells were incubated for 12 h at 37°C and 5% CO 2 . Subsequently, complete neurobasal medium lacking antibiotics replaced the transfection medium following incubation during 3 days at 37°C and 5% CO 2 before western blot analysis or treatment with rLosac for 24 h.
Imaging and quantification of double plasmid transfection experiments Acquisition of GFP and mCherry fluorescence from doubletransfected neurons was performed using confocal microscope (Zeiss LSM 700, Zeiss, Feldbach, Switzerland) at 963 magnification. Three-dimensional (3D) images were reconstructed from 19 serial sections of 0.34 lm thickness using bitplane Imaris software (Zurich, Switzerland) as described previously (Pierre et al. 2009 ) with few modifications. The relative quantification of the membrane labeling of MCT2 was performed in two steps. First, using the colocalization function of ZEN software (Zeiss LSM 700), the portion of colocalization for the green (GFP-MCT2) signal with the red (mCherry) signal was determined (appearing as yellow fluorescence signal). This fraction of the total green fluorescence intensity represented the intracytoplasmic localization of MCT2. Then, by subtracting the value corresponding to the intracytoplasmic signal from the total green fluorescence intensity, we obtained the fraction corresponding to the MCT2 membrane labeling. The crosshair setting was performed using a mCherry-only control sample and a MCT2-GFP-only control sample.
Statistical analysis
All data are presented as the mean AE standard deviation (SD) from at least three independent batches of culture, with n representing the total number of independent replicates indicated in the respective figure legend unless indicated otherwise. Statistical comparison between groups was done using a Student's t-test or an appropriate ANOVA followed by Bonferroni's or Dunnett's post-test using Prism 6.01 or 7.03 (GraphPad Software, CA, USA). Significance was set at p < 0.05. For this study randomization and blinding procedures were not performed. No normality test was used to test the normality of data. No test for outliers was conducted on the data.
Results rLosac enhances viability of B27 supplement-deprived primary cultures of mouse cortical neurons It was demonstrated previously that rLosac offers cytoprotection to cells cultured with nutrient deprivation (AlvarezFlores et al. 2011; Bosch et al. 2016) . To determine the effect of rLosac on neuronal viability under similar conditions, B27 supplement was withdrawn from the medium of primary cultures of mouse cortical neurons and cell viability was determined after 24 h with or without 20 nM of rLosac. B27-supplement deprivation caused a loss of cellular integrity and neuronal death, while rLosac conferred apparent protection (Fig. 1a) . This qualitative observation was corroborated by the quantitative MTT results (Fig. 1b) , which showed that cell viability was significantly reduced with B27 supplement-deprivation (42.43 AE 1.95% of cell viability compared to neurons cultured in complete neurobasal medium considered as 100%). In contrast, rLosac caused an apparent dose-dependent increase in viability of B27 supplement-depleted neurons becoming statistically significant at the concentration of 20 nM (51.16 AE 1.95 vs. 42.43 AE 1.95% of cell viability by the MTT assay, for rLosac and control, respectively, n = 9, *p < 0.05 vs. control). Similar results were found with the LDH assay, 20 nM of rLosac inducing a significant reduction in LDH release (12.57 AE 0.93 vs. 15.82 AE 1.54% of LDH release, for rLosac and control, respectively, n = 9, *p < 0.05 vs. control). Neuronal viability was also evaluated as a function of time. After 24 h of B27 supplement deprivation, cell viability of control cells was reduced as measured by the MTT assay (100.00 AE 4.8 vs 37.35 AE 0.85% of cell viability by the MTT assay, for Ctrl 0 h and 24 h, respectively, n = 9, ***p < 0.001), whereas there was no significant change using the LDH assay (3.80 AE 1.23 vs 7.98 AE 1.01% of LDH release, for Ctrl 0 h and 24 h, respectively, n = 9) (Fig. 1c) . Such a discrepancy between the results of the two tests at 24 h can be explained by the distinct sensitivity of each assay. It was previously reported that the MTT assay can detect cytotoxic effects more rapidly after exposure to the cytotoxic condition and under milder conditions (Fotakis and deprived cortical neurons treated with 20 nM rLosac for different times. *p < 0.05, **p < 0.01, ***p < 0.001 (ANOVA followed by Bonferroni's test). For MTT, values were expressed as percentages of untreated controls cultured in complete neurobasal medium (NBC, set at 100%). For LDH, values were expressed as percentage of maximum LDH release (set at 100%). All data are presented as the mean AE SD, n = 9 independent replicates. NBC, complete neurobasal medium; Ctrl, neurons under B27 supplement-deprivation used as control.
Timbrell 2006). Nevertheless, as monitored with both the MTT and LDH release assays, 20 nM rLosac promoted a marked cell survival effect that was significant after both 48 and 72 h of B27 supplement deprivation (Fig. 1c) .
rLosac preserves or activates Akt, p44/p42 MAPK, and mTOR signaling pathways in cortical neurons To characterize the mechanism leading to the neuroprotective effect of rLosac, the status of various signaling pathways following rLosac treatment was investigated in primary cultures of mouse cortical neurons. B27 supplement withdrawal was previously reported to significantly reduce the phosphorylation of the PI3K/Akt/mTOR and ERK1/2 MAP kinase signaling pathways in cortical and hippocampal neurons (Young et al. 2009; Park et al. 2014) . Thus, it was expected that those pathways could play a role in rLosac enhancement of cell viability and maintenance of MCT2 expression. Phosphorylation levels of Akt on ser473, p44-and p42 MAPK on Thr202/Tyr204, and mTOR on Ser2448 were determined by western blot after cortical neurons were submitted to B27 supplement deprivation alone (Fig. 2a, c , and e) or treated with 20 nM rLosac during five different time periods (5 min, 15 min, 30 min, 1 h and 24 h) (Fig. 2b, d and f) . The removal of B27 supplement from the medium reduced the level of phosphorylation of Akt after 24 h of deprivation, although it did not reach significance (0.61 AE 0.36 vs. 0.90 AE 0.45 phospho-Akt relative intensity, for 24 h and 0 min, respectively, n = 9, p = 0.19) (Fig. 2a) . In contrast, the presence of rLosac partially preserved the level of phosphorylation of Akt after 24 h of treatment compared to the untreated, B27 supplementdeprived control (Ctrl a ) (0.88 AE 0.15 vs. 0.44 AE 0.09 phospho-Akt relative intensity, for 24 h rLosac and 24 h Ctrl a , respectively, n = 9, # p < 0.05) (Fig. 2b) . For ERK1/2 MAPK, a small but transient increase in phospho-p42 but not phospho-p44 was observed up to 1 h after deprivation (Fig. 2c) . This rapid but small and transient effect is most likely a response to the medium change per se and not due to B27 deprivation. However, after 24 h of B27 supplement deprivation, both phospho-p42 (0.07 AE 0.02 vs. 1.16 AE 0.48 of relative intensity, for 24 h and 0 min, respectively, n = 9, p = 0.18) and phospho-p44 (0.10 AE 0.01 vs. 0.66 AE 0.22 of relative intensity, for 24 h and 0 min, respectively, n = 9, **p < 0.01) almost completely disappeared (Fig. 2c) . Interestingly, the presence of rLosac significantly enhanced the levels of phospho-p42 compared to the initial control levels (time 0) for the short time periods (i.e. up to 30 min (6.2 AE 1.27 vs. 1.16 AE 0.48 of relative intensity, for 30 min and 0 min rLosac, respectively, n = 9, **p < 0.01) (Fig. 2d) . Moreover, both phospho-p42 and phospho-p44 levels after 24 h were maintained at higher levels compared to the untreated, B27 supplement-deprived control (Ctrl a ) (3.21 AE 0.78 vs. 0.07 AE 0.02 phospho-p42 relative intensity, for 24 h rLosac and 24 h Ctrl a , respectively, n = 9, ## p < 0.01; and 0.93 AE 0.15 vs. 0.10 AE 0.01 phosphop44 relative intensity, for 24 h rLosac and 24 h Ctrl a , respectively, n = 9, ## p < 0.01) (Fig. 2d) . For mTOR, there was a reduction in both phosphorylated (0.33 AE 0.14 vs. 1.44 AE 0.21 of relative intensity, for 24 h and 0 min, respectively, n = 9, **p < 0.01) and total forms (0.21 AE 0.10 vs. 0.82 AE 0.16 of relative intensity, for 24 h and 0 min, respectively, n = 9, **p < 0.01), which became statistically significant only at 24 h (Fig. 2e) . Interestingly, the presence of rLosac led to an increase in both total and phosphorylated mTOR after 24 h, in contrast to the decrease observed with the B27 supplement deprivation alone (2.30 AE 0.28 vs. 0.45 AE 0.16 total mTOR relative intensity, for 24 h rLosac and 24 h Ctrl a , respectively, n = 9, ### p < 0.001; and 6.95 AE 0.75 vs. 0.84 AE 0.06 phosphomTOR relative intensity, for 24 h rLosac and 24 h Ctrl a , respectively, n = 9, ### p < 0.001) (Fig. 2f) .
rLosac maintains MCT2 protein expression without affecting MCT2 mRNA levels in cortical neurons under B27 supplement deprivation Considering the previously demonstrated importance of MCT2 expression for neurons to resist stressful conditions (Bliss et al. 2004) , the effect of rLosac on MCT2 mRNA and protein levels as a function of time was investigated on primary cultures of neurons (Fig. 3) . First, mouse cortical neurons were cultured in the absence of B27 supplement during different times to assess the effect of B27 supplement deprivation on MCT2 expression. Initially, a small but significant increase in the expression levels of MCT2 mRNA was detected 6 h after B27 supplement deprivation (1.36 AE 0.05 vs. 1.01 AE 0.17 normalized mRNA level, for 6 h and 0 h, respectively, n = 9, **p < 0.01) (Fig. 3a) . It was followed by an important decay in MCT2 mRNA expression that was maximal 24 h after B27 supplement deprivation (0.08 AE 0.01 normalized mRNA level, for 24 h vs. 0 h, n = 9, ***p < 0.001). At the protein level, it was observed that the B27 supplement deprivation led to a fast decrease in MCT2 expression (Fig. 3b) , whereas the expression became hardly detectable after 24 h (0.19 AE 0.17 vs. 0.94 AE 0.47 normalized protein level, for 24 h and 0 min, respectively, n = 9, **p < 0.01). In order to assess the effect of rLosac in condition of nutrient deprivation, the levels of MCT2 mRNA and protein were also determined by quantitative PCR and western blotting, respectively, after different times of treatment. In the first case, levels of MCT2 mRNA remained similar to those without rLosac, with an important decrease after 24 h without B27 supplement (Fig. 3c) . In contrast, MCT2 protein levels in presence of rLosac were maintained close to the control (complete neurobasal medium) level even after 24 h of B27 supplement deprivation, unlike untreated, B27 supplement-deprived neurons in which MCT2 was hardly detectable after 24 h of B27 supplement deprivation (0.83 AE 0.39 vs. 0.04 AE 0.01 . All data are presented as the mean AE SD (n = 9 independent replicates). NBC, complete neurobasal medium. . After that, cortical neurons were treated or not with rLosac (20 nM) for the indicated times. Quantitative analysis is presented as relative intensity (set at 1 for NBC) using specific antibodies for total Akt (a and b) or a-tubulin (c and f) as reference. Statistical analysis was performed using ANOVA followed by Bonferroni's test. *p < 0.05, **p < 0.01 indicate protein levels significantly different from the B27 supplement-deprived control (0 min). # p < 0.05, ## p < 0.01, ### p < 0.001 indicate differences in phospho-Akt, phospho-p44/p42, or phosphomTOR protein levels after 24 h of rLosac treatment significantly different from the 24 h B27 supplement-deprived control (Ctrl a ). All data are presented as the mean AE SD (n = 9 independent replicates). NBC, complete neurobasal medium.
normalized protein level, for 24 h rLosac and 24 h Ctrl a , respectively, n = 9, # p < 0.05) (Fig. 3d) .
rLosac might retain MCT2 protein at the neuronal cell surface In order for MCT2 to be functional and eventually favor the use of energy substrates by neurons, its expression must be maintained at the cell surface. To assess whether rLosac could not only act on total MCT2 protein levels but also preserve the fraction expressed at the cell surface, an experimental approach was used to allow the quantification of MCT2 expression associated with the plasma membrane. First, primary cultures of mouse cortical neurons were cotransfected with two plasmids. One encoding a MCT2 sequence fused with the green fluorescent protein (GFP), whereas the other contained only a sequence for the exclusively cytoplasmically expressed red fluorescent protein mCherry. By doing so, it is possible to distinguish the intracytoplasmic compartment (that will be labeled in red by mCherry; any yellow signal indicative of colocalization with GFP-MCT2 would be considered as intracytoplasmic localization for MCT2) and the MCT2 protein located in the plasma membrane (that will appear as a green signal only as it will not colocalized with mCherry). A similar approach was used successfully previously (Pierre et al. 2009 ). As illustrated in Fig. 4 , a reduction in cell surface expression of MCT2 could be observed following B27 deprivation ( Fig. 4b ; less green visible) as compared to the normal culture condition (Fig. 4a) . But when cultured neurons were treated with rLosac, the level of MCT2 cell surface expression appeared similar to the control condition (Fig. 4c) . Quantification of non-colocalized fluorescence intensity (green signal) corresponding to MCT2 cell surface expression confirmed the significant effect of rLosac in preventing the reduction observed with B27 deprivation (Fig. 4d) .
MCT2 is necessary for rLosac enhancement of neuronal viability MCT2 expression was preserved in response to rLosac treatment under B27 supplement deprivation, up to 24 h, coinciding with an increase in mitochondrial metabolism (i.e. given by the MTT assay) as described above (Fig. 1) . To determine if MCT2 is necessary for the observed rLosac enhancement of B27 supplement-deprived cortical neuron viability, the effect of MCT2 knockdown using specific siRNA (siMCT2) was examined on cell viability with the MTT assay. Knockdown of MCT2 produced a 2.1-fold decrease in MCT2 protein expression, whereas the scrambled Fig. 4 Effect of rLosac on MCT2 cell surface expression in cultured cortical neurons during B27-supplement deprivation. (a-c) Changes in MCT2 surface expression were analyzed using 3D reconstructed images of transfected neurons. Primary cultures of mouse cortical neurons were double transfected with a mCherry plasmid in order to visualize the intracytoplasmic compartment (red) and a MCT2-GFP plasmid (green). Then, transfected neurons were cultured in control condition (a), in the absence of B27 supplement alone (b) or in the presence of 20 nM rLosac (c) during 24 h before imaging. (d) Quantification of MCT2 fluorescence intensity (green signal) located at the neuronal surface in control neurons, B27-deprived neurons and B27-deprived neurons treated with rLosac. Statistical analysis was performed on four transfected cells in each condition, using ANOVA followed by Dunnett's test. All data are presented as the mean AE SD (n = 4 neurons from 4 different culture wells).
siRNA used as a control did not have an effect (0.45 AE 0.15 vs. 0.95 AE 0.20% of normalized protein level, for siMCT2 and scramble, respectively, n = 9, *p < 0.05) (Fig. 5a ). When B27 supplement-deprived cells were treated with 20 nM of rLosac during 24 h and viability assessed with the MTT assay, results showed that 1) as previously observed, rLosac enhanced mitochondrial metabolism (56.27 AE 8.99 vs. 35. 87 AE 5.63% of cell viability, for 24 h rLosac and 24 h Ctrl, respectively, n = 12, ***p < 0.001) 2) MCT2 knockdown prevented the neuroprotective activity of rLosac (31.8 AE 3.17 vs. 53.4 AE 3.59% of cell viability, for 24 h rLosac + siMCT2 and 24 h rLosac + scramble, respectively, n = 12, ***p < 0.001) (Fig. 5b) .
rLosac stimulates lactate uptake in B27 supplementdeprived cortical neurons To determine whether the preserved MCT2 protein expression caused by rLosac could lead to a significantly higher lactate utilization, lactate uptake by mouse cortical neurons was measured in neurons maintained under classical culture conditions, in B27 supplement-deprived neurons for 24 h and in B27-deprived neurons for 24 h plus treatment with 20 nM of rLosac (Fig. 6) . First, 24 h of B27 supplement deprivation led to a reduction in lactate uptake (31.66 AE 1.26 vs. 49.97 AE 6.45 pmoles/mg, for NBC and B27 supplement deprived control, respectively, n = 9) which is consistent with the previously described reduction in MCT2 expression. The observed impairment of lactate uptake could be partially prevented by the treatment of cortical neurons with 20 nM of rLosac during 24 h (38.81 AE 2.37 vs. 31.66 AE 1.26 pmoles/ mg, for rLosac-treated neurons and B27 supplement-deprived neurons alone, respectively, n = 9, **p < 0.01).
rLosac enhances the beneficial effect of lactate on neuronal viability In order to evaluate the combined neuroprotective effects of lactate and rLosac on B27 supplement-deprived cortical neurons, cells were treated with lactate (range 1-20 mM) alone or in combination with 20 nM of rLosac for 24 h. The Fig. 5 Effect of MCT2 knockdown on rLosac enhancement of cell viability in B27 supplement-deprived cultured cortical neurons. Primary cultures of mouse cortical neurons were transfected with 300 nM of MCT2-specific siRNA or unspecific scrambled siRNA (Scr) before rLosac treatment for 24 h in B27 supplement deprivation conditions. (a) MCT2 knockdown was confirmed by western blot analysis. *p < 0.05 (unpaired Student's t-test, n = 9 independent replicates).
(b) MTT assay was performed after 24 h in B27 supplement deprivation conditions with or without exposure to 20 nM of rLosac. ***p < 0.001 (ANOVA followed by Bonferroni's test, n = 12 independent replicates). For MTT, values were expressed as percentages of untreated controls cultured in NBC (set at 100%). All data are presented as the mean AE SD. NBC, complete neurobasal medium; Ctrl, neurons under B27 supplement deprivation used as control; Scr, scramble. Fig. 6 Effect of rLosac on lactate uptake in B27 supplement-deprived cultured cortical neurons. Primary cultures of mouse cortical neurons were cultured in the absence of B27 supplement alone or in the presence of 20 nM rLosac during 24 h before lactate uptake assay was performed. Unpaired Student's t-test was used to evaluate differences in 14 C-lactate uptake. **p < 0.01 indicates rLosac-stimulated lactate uptake significantly different from the B27 supplement-deprived control (Ctrl). Data are presented as the mean AE SD, n = 9 independent replicates. NBC, complete neurobasal medium.
range of lactate concentrations was based on the concentrations of lactate shown to be neuroprotective against excitotoxicity as previously seen (Jourdain et al. 2016; LlorenteFolch et al. 2016) . First, lactate alone was able to induce a concentration-dependent neuroprotection of B27 supplementdeprived neurons as determined with the MTT assay (Fig. 7a) , becoming statistically significant at the concentration of 5 mM and remaining up to 20 mM (69.83 AE 3.54 vs. 59.25 AE 2.66% of cell viability by the MTT assay, for 20 mM lactate and B27 supplement-deprived control, respectively, n = 12, ***p < 0.001). Concomitantly, a significant reduction in LDH release was observed with 20 mM lactate (10.53 AE 0.86 vs. 12.21 AE 1.33% of LDH release, for 20 mM Lactate and B27 supplement-deprived control, respectively, n = 6, *p < 0.05) (Fig. 7b) . In presence of both lactate and rLosac, neuroprotection was higher than with lactate alone (82.71 AE 6.31 vs. 69.83 AE 3.54% cell viability, for 20 nM Losac + 20 mM Lactate and 20 mM Lactate alone, respectively, n = 12, ***p < 0.001) (Fig. 7c) . Similarly, LDH release was more reduced when lactate and rLosac were added together than with lactate alone (10.04 AE 1.05 vs. 11.88 AE 1.89% of LDH release, for 20 nM Losac + 20 mM Lactate and 20 mM Lactate alone, respectively, n = 12, ***p < 0.001) (Fig. 7d) .
Discussion
Several studies have shown that the action of neuroprotective substances is often associated with effects on neuroenergetics. They often promote the use of monocarboxylates including lactate by modulating the expression of one of their transporters such as MCT2 (Pellerin 2003; Sapolsky 2003; Bliss et al. 2004; Robinet and Pellerin 2010; Demetrius et al. 2014; Castillo et al. 2015) . In parallel, several neurological diseases (e.g. Alzheimer's and Parkinson's diseases) or stress conditions exhibit an early deficit in neuronal energy metabolism (Demetrius et al. 2014) . Thus, the search for new compounds with neuroprotective properties that could specifically modulate energy metabolism of neurons becomes of great interest. In this context, rLosac emerges as an interesting candidate as neuroprotective agent. Indeed, rLosac was shown to enhance cell viability of endothelial cells (Alvarez-Flores et al. 2006) and fibroblasts (Bosch et al. 2016 ) which have been serum-deprived, a major stress condition for cells including neurons. Second, rLosac similarity with neural cell adhesion molecules also suggests that it may act on neurons as well (Alvarez-Flores et al. 2011) . So far, the proposed mechanism of rLosac cytoprotective activity implicated a reduction in oxidative Fig. 7 Concentration-dependent effect of Lactate and rLosac on cell viability in cultured cortical neurons under B27 supplement-deprived condition. Primary cultures of mouse cortical neurons were incubated with various concentrations of lactate alone (a and b) or in the presence of 20 nM rLosac (c and d) for 24 h after which cell viability was measured using MTT and lactate dehydrogenase (LDH) assays. Statistical analysis was performed using ANOVA followed by Bonferroni's test (*p < 0.05, **p < 0.01, ***p < 0.001). All data are presented as the mean AE SD, n = 12 (a), 6 (b), 12 (c), and 12 (d) independent replicates. For MTT, values were expressed as percentages of untreated controls cultured in NBC (set at 100%). For LDH, values were expressed as percentage of maximum LDH release (set at 100%). NBC, complete neurobasal medium; Ctrl, neurons under B27 supplement deprivation used as control.
stress via a decreased release of reactive oxygen species generated by serum deprivation, thereby preventing damage and loss of mitochondrial function, and also by reducing caspase 3 and therefore apoptosis (Alvarez-Flores et al. 2006; Bosch et al. 2016) . High levels of reactive oxygen species can be toxic, especially for cells with a long lifespan such as neurons. Indeed, almost all forms of neurodegenerative diseases are associated with oxidative stress (Cobb and Cole 2015) . However, our results show that while rLosac can be neuroprotective following B27 supplement deprivation stress, this effect primarily involves a putative preservation of energy supply.
Monocarboxylate transporters have been associated with neuroprotection in several conditions. For example MCT4, an exclusively astrocytic transporter, appears to play a role in neuroprotection during cerebral ischemia (Hong et al. 2015) . MCT2 is the monocarboxylate transporter predominantly expressed by neurons and it allows the uptake of lactate across the plasma membrane to be used as an alternative energy substrate (Halestrap and Price 1999; Pierre et al. 2000 Pierre et al. , 2002 . Our study reveals that primary mouse cortical neurons cultured up to 24 h in neurobasal medium lacking B27 supplement led to an impairment of cell viability as well as a decrease in protein and mRNA expression of MCT2. Interestingly, a treatment with rLosac was able to promote cell viability in B27 supplement-deprived cortical neurons and MCT2 expression appears to be key as revealed by our knockdown experiment. However, rLosac only affected MCT2 protein expression, maintaining its total level and cell surface expression close to those observed in a complete medium. Such an effect suggests that rLosac either enhances MCT2 protein synthesis or reduces MCT2 protein degradation while putatively retaining the amount present at the cell surface.
A translational regulation of MCT2 in primary cultures of mouse cortical neurons was reported previously for insulin, IGF-1, noradrenaline, and BDNF (Chenal and Pellerin 2007; Chenal et al. 2008; Robinet and Pellerin 2010) . In these studies, a role for the activation of the PI3K/Akt/ mTOR and ERK1/2 (p42/p44) MAPK pathways in regulating the expression of MCT2 at the translational level was evidenced. The mTOR pathway plays a critical role in regulating energy metabolism and important neuronal functions such as synaptic plasticity, memory storage, and cognition (Hoeffer and Klann 2010; Bockaert and Marin 2015) , whereas ERK or p42/p44 MAP kinase and PI3K/ AKT pathways modulate signaling for neuroprotection, cell migration, and plasticity (Read and Gorman 2009; Hutton et al. 2017) . The activation of both pathways is known to promote cell survival while a reduced activation has been observed upon B27 supplement deprivation in cultured neurons (Young et al. 2009; Park et al. 2014) . Our findings are consistent with these observations as we observed reduced phosphorylations of Akt, ERK1/2 (p42/p44) MAP kinase and mTOR following B27 supplement deprivation which were preserved with rLosac treatment. Previously, it has been shown that rLosac can promote cell survival in serum-deprived endothelial cells (HUVECs) (Alvarez-Flores et al. 2006) , and that the activation of the p42/p44 MAP kinase pathway is involved in the observed effects through a mechanism that remains to be characterized (M.P. Alvarez-Flores' unpublished data). It is noteworthy that Insulin, IGF-1, noradrenaline, and BDNF, which activate these signaling pathways and enhance MCT2 expression in neurons, have been involved in different forms of synaptic plasticity. Therefore it seems plausible that MCT2 plays an important role in sustaining synaptic function as suggested previously (Pierre et al. 2009 ). In these conditions, however, it remains to be demonstrated whether maintenance of MCT2 expression by rLosac leads also to the preservation of synaptic transmission.
Several studies have suggested that lactate could offer neuroprotection in several pathological conditions such as excitotoxicity or ischemia by acting either as a receptor agonist on the HCA1 receptor or as an energy substrate (Pellerin 2003; Berthet et al. 2012; Castillo et al. 2015) . Furthermore, it was shown in traumatic brain injury patients that lactate could represent a useful neuroprotective agent if it can be oxidized by the tissue (Patet et al. 2015; Quintard et al. 2016) . In this study, our results suggest that rLosac is able to increase neuronal viability in conditions of B27 supplement deprivation by facilitating lactate utilization via the maintenance of MCT2 protein expressed at the cell surface. Indeed, the neuroprotective effect of lactate on B27 supplement-deprived cells is enhanced in presence of rLosac which in parallel increases lactate uptake. Thus, our data confirm that promoting lactate utilization as an alternative energy substrate represents a valid approach for neuroprotection. Moreover, our findings may pave the way for the identification of a novel class of neuroprotective agents which would act by boosting neuroenergetics under stress conditions. All experiments were conducted in compliance with the ARRIVE guidelines.
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